Future of Lung Cancer Precision Medicine with Dr. Andrea Mazzocchi

from Lungcast · host American Lung Association & HCPLive

Data beget progress. Such is the promise and hope of artificial intelligence, particularly machine learning, to match lung cancer patients with their optimal treatments. In this episode, Dr. Andrea Mazzocchi, Co-founder and CEO of Known Medicine, dissects the art and the science of how profiling biomarkers, epigenetics and the microenvironment may provide the synergy needed to revolutionize the oncologic landscape.

Episode metadata supplied by the publisher feed · Published Jul 19, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Future of Lung Cancer Precision Medicine with Dr. Andrea Mazzocchi

0:00 37:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Lungcast?

This episode is 37 minutes long.

When was this Lungcast episode published?

This episode was published on July 19, 2021.

Can I download this Lungcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!